- Report
- April 2023
- 113 Pages
Global
€3384EUR$3,500USD£2,906GBP
- Drug Pipelines
- July 2018
- 616 Pages
Global
From €21269EUR$22,000USD£18,269GBP
Sorilux is a topical foam medication used to treat plaque psoriasis, a chronic skin condition characterized by red, scaly patches. It contains calcipotriene, a synthetic form of vitamin D3, which helps reduce inflammation and slow the growth of skin cells. Sorilux is available in both prescription and over-the-counter forms. It is typically applied twice daily to affected areas of the skin.
The Sorilux market is composed of a variety of products, including creams, ointments, and foams. These products are designed to reduce the symptoms of psoriasis, such as itching, redness, and scaling. They are available in both prescription and over-the-counter forms.
Some of the companies in the Sorilux market include Galderma, Mylan, and Sun Pharmaceuticals. Other companies include AbbVie, Amgen, and Pfizer. Show Less Read more